Table 2.
Group | Trial | Absolute VO2 | Intra-groupp-value | Relative VO2 | Intra-groupp-value | VEO2 (VE/VEO2) | Intra-groupp-value | Heart rate (bpm) | Intra-groupp-value |
---|---|---|---|---|---|---|---|---|---|
DHA | Baseline | 2729±305 | } p = 0.001* | 36.6±5.0 | } p = 0.001* | 26.83±2.30 | } p = 0.013* | 160±11 | } p = 0.683 |
Post | 3046±335 | 41.2±5.4 | 28.50±2.40 | 160±13 | |||||
PLA | Baseline | 2792±340 | } p = 0.503 | 37.2±5.7 | } p = 0.418 | 27.85±3.43 | } p = 0.870 | 162±12 | } p = 0.242 |
Post | 2846±357 | 38.1±5.2 | 27.95±2.37 | 163±12 | |||||
Inter-group · Time −1 | p = 0.025* | p = 0.024* | p = 0.084 | p = 0.756 |
VE/VEO2: Ventilatory equivalent for oxygen. Values are presented as mean ± standard deviation (SD). * p <0.05